Two stock leaders with the potential to outperform the market by 2030

Investing in stock markets can be erratic, but a long-term horizon brings a higher probability of interesting returns. Many investors opt for index funds tracking the S&P 500, but those seeking higher appreciation can focus on specific companies with the potential to outperform the market.

Analysts therefore highlight the qualities of two stocks that may outperform the market by 2030. Which stocks are they?

Amgen - a strong pharmaceutical company with a growing dividend

Amgen $AMGN is one of the leading pharmaceutical companies and its growth potential is significant. Key products in its portfolio are Tezspire, a treatment for asthma, and Tepezza, for the treatment of eye disease associated with thyroid disorders. In addition, Tezspire is undergoing further clinical trials and has the potential to expand its approved indications.

Amgen is also expanding in the treatment of obesity, which is currently one of the fastest growing segments of the pharmaceutical market. Its promising candidate

Read the full article for free?
Go ahead 👇

Do you have an account? Then log in . Or create a new one .

No comments yet
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade